Purpose of Review

To describe the INTERASPIRE scientific protocol—an international survey of secondary prevention of coronary heart disease (CHD).

Recent Findings

This international survey is being conducted through National Societies of Cardiology in selected countries from each of the six WHO regions and has the following overall aims: (i) describe prevalence of cardiometabolic and renal risk factors together with biomarkers in CHD patients; (ii) describe current risk factor management through lifestyle changes and cardioprotective drug therapies; (iii) provide an objective assessment of clinical implementation of preventive care by comparison with the lifestyle and risk factor targets defined in international and national guidelines; (iv) investigate the reasons for variation in preventive cardiology practice between regions and countries; and (v) promote the principles of best preventive cardiology practice.

Summary

This international survey will provide a unique picture of CHD patients; their cardiometabolic, renal and biomarker status; lifestyle and therapeutic management; and the quality of preventive care provided in all WHO regions.

中文翻译：

---

INTERASPIRE：对冠心病患者的国际调查；他们的心脏代谢、肾脏和生物标志物状态；以及在世卫组织所有区域提供的预防保健质量

审查目的

描述 INTERASPIRE 科学方案——一项对冠心病 (CHD) 二级预防的国际调查。

最近的发现

这项国际调查是通过国家心脏病学会在世卫组织六个区域中的每一个区域的选定国家进行的，总体目标如下：(ii) 描述当前通过生活方式改变和心脏保护药物治疗的风险因素管理；(iii) 通过与国际和国家指南中定义的生活方式和风险因素目标进行比较，对预防性护理的临床实施进行客观评估；(iv) 调查地区和国家之间预防心脏病学实践差异的原因；(v) 推广最佳预防心脏病学实践的原则。

概括

这项国际调查将提供 CHD 患者的独特情况；他们的心脏代谢、肾脏和生物标志物状态；生活方式和治疗管理；以及在世卫组织所有区域提供的预防保健质量。